ArticleTheranostics2021

Genomic and transcriptional alterations in first-line chemotherapy exert a potentially unfavorable influence on subsequent immunotherapy in NSCLC.

Yayi He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.